James Leslie - COO & CFO, Celmatix Inc.
Matthew Owens - Deployment Strategist, Palantir Technologies. Co-Founder, Synaptic. Advisor and Founding Executive Director Emeritus, Harlem Biospace
Pull back the curtain and find out how your patent application might hold up under prosecution by the U.S. Patent and Trademark Office (“USPTO”). Columbia University’s Chief Patent Counsel Jeff Sears will demonstrate a mock patent examination, showing how the USPTO looks for prior art, evaluates claims made in patent applications, and finally decides whether to award a patent.
ABOUT THE SPEAKER:
Jeff serves as Columbia's Chief Patent Counsel in the Office of the General Counsel’s Patent and Licensing Group. His practice encompasses all aspects of patent law, including portfolio management, strategic counseling, licensing and post-licensing compliance, litigation, and legislative and regulatory patent matters. Jeff holds an S.B. in physics from MIT, an M.A. and Ph.D. in physics from SUNY Stony Brook, and a J.D. from NYU. He is admitted to practice law in New York and before the U.S. Patent and Trademark Office.
Columbia Technology Ventures’ Executive Director Orin Herskowitz will talk about the fast-changing and ever-growing world of patenting and licensing early-stage university technologies, including examples of scientific inventions, how patent decisions get made, and how license agreements are negotiated, both within Columbia and across the industry.
For those of you who are new to tech transfer, our core objective is to facilitate the transfer of inventions from academic research to outside organizations for the benefit of society on a local, national and global basis. Each year, CTV manages nearly 400 invention disclosures from faculty, 100 license deals and 15+ new start-ups. CTV currently has over 1,200 patent assets available for licensing, across research fields such as bio, IT, cleantech, devices, nanotechnology, and material science.
ABOUT THE SPEAKER
Orin Herskowitz, VP of Intellectual Property and Tech Transfer for Columbia University and Executive Director of Columbia Technology Ventures (CTV), is also an Adjunct Professor at Columbia’s Business and Engineering Schools. He has been a Board Member or Advisor to a number of innovation and entrepreneurship-focused initiatives in NYC, including the NYC Media Lab, NYC ACRE, the Coulter Translational Partnership, PowerBridgeNY, and HarlemBiospace.
Columbia Technology Ventures is the tech transfer office of Columbia University. Our core objective is to facilitate the transfer of inventions from academic research to outside organizations for the benefit of society on a local, national and global basis. Each year, CTV manages more than 350 invention disclosures from faculty, 100 license deals and 15 new start-ups. CTV currently has over 1200 patent assets available for licensing, across research fields such as bio, IT, cleantech, devices, nanotechnology, and material science. Columbia Technology Ventures has a particular focus on start-up companies. Over the years, CTV has been involved with launching over 200 companies based on Columbia's technologies. Of these companies, over 40 have received VC funding, with over 25 successful acquisitions or IPOs to date. For more information, please visit www.techventures.columbia.edu.
INTERPHEX is a premier pharmaceutical, biotechnology, and medical device development and manufacturing event and sponsored by the Parenteral Drug Association (PDA). Dedicated to Innovation, Technologies and Knowledge, the show focuses on the entire product development life cycle. Held in New York City, it brings over 10,000 global industry professionals together with 600+ suppliers through a unique combination of exhibition, no cost technical education, workshops, partnering opportunities, and networking events.